Privo Technology’s CEO, Manijeh Goldberg, speaks at IDEASTREAM, MIT Deshpande Center Symposium.
Buccal Delivery of Chemotherapy to treat.
Our Oral Cancer treatment receives MIT’s Innovation Award two years in a row.
The project was awarded over $300,000 in funding from MIT’s Deshpande Innovation Center in 2012 and 2013 to support the company’s drug development activities. We are proud to receive these very competitive awards and honored to be amongst some...
- © Web Design & Development
- © UX Strategy & Digital Branding
